Unbiased Analysis of Today's Healthcare Issues
The Digital Therapeutics Alliance defines a digital therapeutic (DTx) as “evidence-based therapeutic interventions that are driven by high-quality software programs to prevent, manage, or treat a medical disorder or disease.” One key question is what factors do US payers take into account when evaluating DTx and how does that differ from standard pharmaceuticals. A paper…
An AMA report out this month surveys physicians regarding their perceptions of digital health. This year’s survey replicates similar surveys in 2016 and 2019. Some of the key findings are: There has been an increase in the percentage of physicians that feel there are advantages in leveraging digital health solutions. The percentage of physicians who…
The American Medical Association surveyed its members between November and December of 2021 to examine their current use of telehealth. As outliend in the “2021 Telehealth Survey Report“, the key findings of the survey were: Uptake. 85% of physician use telehealth. 56% of respondents said they believe they will increase telehealth use in their practices.…
What role should digital therapeutics (DTx) play in our treatment landscape? What regulatory and access processes need to be established to be sure these treatments are safe, effective and high value? What evidence is needed to support claims of safety, efficacy and value? These questions and more were tackled as part of an AMCP Partnership…
Will telehealth widen or reduce health disparities? Telehealth may make it easier for individuals who lack transportation to get access to medical care; on the other hand, those without high-speed internet or good cell phone connections could be disadvantaged. In a recent report, NCQA examined the future of telehealth and examined how to make sure…
That is the title of a paper published today with my co-authors Felicia Forma, Kevin Chiu, Jason Shafrin, Dusica Hadzi Boskovic, and S Phani Veeranki. The subtitle is: Caregiver preferences for health technology tools to monitor medication adherence among patients with serious mental illness. The paper abstract is below: Background Adherence to antipsychotic medication is…
An interesting report from the European Observatory on Health Systems and Policies examined the “Use of digital health tools in Europe: before, during and after COVID-19“. Digital health is important not only because the technologies facilitate communication and disease monitoring, but also the technologies facilitate the creation of data that can be used to better…
That is the title of a recent commentary published in the Journal of Clinical Pathways with my colleague David Gruber. New digital technologies have the potential to greatly improve our healthcare system on multiple fronts. Telemedicine allowed many patients to communicate with their doctors during the COVID-19 pandemic; during the height of the pandemic, 30% of…
This is the title of a paper published today with co-authors Suepattra May, Caroline Huber, Meaghan Roach, Wade Aubry, Darius Lakdawalla, John Kane, and Felicia Forma. The subtitle is “Qualitative Case Study of Glucose Monitoring Technology“. The abstract is below. Background: Evaluation of patients with serious mental illness (SMI) relies largely on patient or caregiver…
With the rise of telemedicine due to the COVID-19 pandemic and–before that–the increasing ubiquity of smartphones, digital medicine appears to be the wave of the future. At least that is the topic of a recent article on health care and technology in The Economist. Despite all this hope, we are far from a fully digital…